Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids

NCT00853567 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
71
Enrollment
INDUSTRY
Sponsor class

Stopped Repros stopped the study for safety and FDA put the study on hold for safety.

Conditions

Interventions

Sponsor

Repros Therapeutics Inc.